Stock is sitting in the low $1s right now and this might be the last time you see it there. Q1 2026 revenue hit $25.6M at the top of guidance, EPS loss shrank to ($0.26) from ($1.09) a year ago, …
Not financial advice. I’m just staring at numbers instead of sleeping. Here’s what caught my eye: 33.23% of the float sold short 31.6M shares short **8.53 days to cover** Institutions reportedly holding over 100% of shares available through reporting/lending mechanics …
I’ve been looking at DRTS after the Tolmar partnership, and I’m trying to separate the real signal from the usual small-cap biotech noise. The deal gives Alpha Tau funding, manufacturing support, and possible milestone payments, which is clearly helpful. But …
Posting some DD on Medicus Pharma (Nasdaq: MDCX), a clinical stage biotech trading around $0.30. Not a recommendation - sharing what I've found, do your own DD. **The company:** Medicus is developing SkinJect, a microneedle patch (doxorubicin containing microneedle arrays) …
The stock is down 60% over the past year largely because of a deeply dilutive May offering priced at a 42% discount, triggering a 44% single-day crash it also created the current gap: **a company whose two financial assets alone …
NUBURU is pivoting into directed-energy and counter-drone systems. Laser-based anti-drone tech is getting serious defense funding right now — interesting space to watch even if this particular name has a rough history. [NUBURU Expands Defense & Security Platform](https://www.businesswire.com/news/home/20260604501766/en/NUBURU-Expands-Defense-Security-Platform-with-Laser-Arm-Initiative-Targeting-the-Fast-Growing-Directed-Energy-and-Counter-UAS-Markets)
$LBRG News June 04, 2026 Ladybug Resource Group Inc. Unveils Proprietary AI-Driven Digital Infrastructure, Reopening Efficiency in the Global EV Supply Chain https://finance.yahoo.com/sectors/technology/articles/ladybug-group-inc-unveils-proprietary-134000311.html
Ray Dalio (founder of Bridgewater Associates) remains deeply concerned about the **long-term debt cycle**, geopolitical tensions, and a potential breakdown of the existing monetary/world order. He does not see an imminent classic recession as the main risk, but something potentially …
It is interesting to observe how Charlie's Holding has earned its uplisting through long and hard work. I am an investor myself, and I view the future positively. I understand that many people are cautious—and rightly so; that is a …